147 related articles for article (PubMed ID: 17022786)
1. The yield of expanding the therapeutic time window for tPA.
Owe JF; Sanaker PS; Naess H; Thomassen L
Acta Neurol Scand; 2006 Nov; 114(5):354-7. PubMed ID: 17022786
[TBL] [Abstract][Full Text] [Related]
2. Why are eligible thrombolysis candidates left untreated?
Hills NK; Johnston SC
Am J Prev Med; 2006 Dec; 31(6 Suppl 2):S210-6. PubMed ID: 17178305
[TBL] [Abstract][Full Text] [Related]
3. Prioritizing interventions to improve rates of thrombolysis for ischemic stroke.
California Acute Stroke Pilot Registry (CASPR) Investigators
Neurology; 2005 Feb; 64(4):654-9. PubMed ID: 15728287
[TBL] [Abstract][Full Text] [Related]
4. Obstacles to the use of intravenous tissue plasminogen activator for acute ischemic stroke. Is time the only barrier?
Laloux P; Thijs V; Peeters A; Desfontaines P
Acta Neurol Belg; 2007 Dec; 107(4):103-7. PubMed ID: 18416282
[TBL] [Abstract][Full Text] [Related]
5. Administration of tissue plasminogen activator for acute ischemic stroke in a rural Wisconsin hospital.
Charipar R; Charipar E
WMJ; 2008 Jul; 107(4):176-80. PubMed ID: 18702433
[TBL] [Abstract][Full Text] [Related]
6. Influence of the stroke code activation source on the outcome of acute ischemic stroke patients.
de la Ossa NP; Sánchez-Ojanguren J; Palomeras E; Millán M; Arenillas JF; Dorado L; Guerrero C; Abilleira S; Dávalos A
Neurology; 2008 Apr; 70(15):1238-43. PubMed ID: 18322264
[TBL] [Abstract][Full Text] [Related]
7. Acute stroke management in the elderly.
Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
[TBL] [Abstract][Full Text] [Related]
8. Utilization of intravenous tissue plasminogen activator for ischemic stroke: are there sex differences?
Allen NB; Myers D; Watanabe E; Dostal J; Sama D; Goldstein LB; Lichtman JH
Cerebrovasc Dis; 2009; 27(3):254-8. PubMed ID: 19176959
[TBL] [Abstract][Full Text] [Related]
9. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
[TBL] [Abstract][Full Text] [Related]
10. The use of intravenous recombinant tissue plasminogen activator in acute ischemic stroke.
Kahn JH; Viereck J; Kase C; Jeerakathil T; Romero R; Mehta SD; Kociol R; Babikian V
J Emerg Med; 2005 Oct; 29(3):273-7. PubMed ID: 16183445
[TBL] [Abstract][Full Text] [Related]
11. Utilization of intravenous tissue plasminogen activator for acute ischemic stroke.
Katzan IL; Hammer MD; Hixson ED; Furlan AJ; Abou-Chebl A; Nadzam DM;
Arch Neurol; 2004 Mar; 61(3):346-50. PubMed ID: 15023810
[TBL] [Abstract][Full Text] [Related]
12. [Thrombolysis in stroke: inappropriate consideration of the 'window period' as the time available].
Maestre-Moreno JF; Fernández-Pérez MD; Arnáiz-Urrutia C; Mínguez A; Navarrete-Navarro P; Martínez-Bosch J
Rev Neurol; 2005 Mar 1-15; 40(5):274-8. PubMed ID: 15782357
[TBL] [Abstract][Full Text] [Related]
13. The use and misuse of thrombolytic therapy within the Veterans Health Administration.
Keyhani S; Arling G; Williams LS; Ross JS; Ordin DL; Myers J; Tyndall G; Vogel B; Bravata DM
Med Care; 2012 Jan; 50(1):66-73. PubMed ID: 22182924
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the reasons for exclusion from tPA therapy after early arrival in acute stroke patients.
García-Moncó JC; Pinedo A; Escalza I; Ferreira E; Foncea N; Gómez-Beldarrain M; Ruiz-Ojeda J; Mateo I; Mediavilla J; Basterretxea JM
Clin Neurol Neurosurg; 2007 Jan; 109(1):50-3. PubMed ID: 16887258
[TBL] [Abstract][Full Text] [Related]
15. Reducing in-hospital delay to 20 minutes in stroke thrombolysis.
Meretoja A; Strbian D; Mustanoja S; Tatlisumak T; Lindsberg PJ; Kaste M
Neurology; 2012 Jul; 79(4):306-13. PubMed ID: 22622858
[TBL] [Abstract][Full Text] [Related]
16. Time to hospital arrival, use of thrombolytics, and in-hospital outcomes in ischemic stroke.
Qureshi AI; Kirmani JF; Sayed MA; Safdar A; Ahmed S; Ferguson R; Hershey LA; Qazi KJ;
Neurology; 2005 Jun; 64(12):2115-20. PubMed ID: 15985583
[TBL] [Abstract][Full Text] [Related]
17. Intravenous thrombolysis for ischaemic stroke: short delays and high community-based treatment rates after organisational changes in a previously inexperienced centre.
Tveiten A; Mygland A; Ljøstad U; Thomassen L
Emerg Med J; 2009 May; 26(5):324-6. PubMed ID: 19386862
[TBL] [Abstract][Full Text] [Related]
18. Why ischemic stroke patients do not receive thrombolytic treatment: results from a general hospital.
van den Berg JS; de Jong G
Acta Neurol Scand; 2009 Sep; 120(3):157-60. PubMed ID: 19719807
[TBL] [Abstract][Full Text] [Related]
19. Distance from home to hospital and thrombolytic utilization for acute ischemic stroke.
Acharya AB; Nyirenda JC; Higgs GB; Bloomfield MS; Cruz-Flores S; Connor LT; Lee JM; Leet TL
J Stroke Cerebrovasc Dis; 2011; 20(4):295-301. PubMed ID: 20634096
[TBL] [Abstract][Full Text] [Related]
20. Telephonic guidance of systemic thrombolysis in acute ischemic stroke: safety outcome in rural hospitals.
Vaishnav AG; Pettigrew LC; Ryan S
Clin Neurol Neurosurg; 2008 May; 110(5):451-4. PubMed ID: 18353532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
